Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patient Readmission | 7 | 2024 | 163 | 2.260 |
Why?
|
| Patient Discharge | 7 | 2022 | 154 | 2.180 |
Why?
|
| Retrospective Studies | 15 | 2023 | 2447 | 1.250 |
Why?
|
| Transitional Care | 2 | 2024 | 20 | 1.100 |
Why?
|
| Hospitals | 3 | 2022 | 80 | 0.920 |
Why?
|
| Delivery of Health Care, Integrated | 5 | 2022 | 531 | 0.890 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2022 | 330 | 0.890 |
Why?
|
| Telemedicine | 2 | 2024 | 182 | 0.820 |
Why?
|
| Dexamethasone | 1 | 2022 | 12 | 0.810 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 25 | 0.800 |
Why?
|
| Humans | 36 | 2024 | 17611 | 0.790 |
Why?
|
| Emergency Service, Hospital | 8 | 2023 | 358 | 0.730 |
Why?
|
| Medical Audit | 2 | 2020 | 38 | 0.720 |
Why?
|
| Outpatients | 2 | 2020 | 107 | 0.710 |
Why?
|
| Medical Records | 2 | 2020 | 100 | 0.700 |
Why?
|
| Self Report | 2 | 2022 | 251 | 0.660 |
Why?
|
| Aged | 19 | 2024 | 6095 | 0.650 |
Why?
|
| Disease Progression | 1 | 2020 | 264 | 0.650 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 197 | 0.600 |
Why?
|
| Male | 23 | 2023 | 10008 | 0.590 |
Why?
|
| Female | 27 | 2024 | 12608 | 0.590 |
Why?
|
| Research Design | 1 | 2020 | 374 | 0.580 |
Why?
|
| Skilled Nursing Facilities | 1 | 2017 | 8 | 0.580 |
Why?
|
| Papillomavirus Infections | 3 | 2024 | 133 | 0.580 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 55 | 0.560 |
Why?
|
| Acute Coronary Syndrome | 3 | 2021 | 18 | 0.540 |
Why?
|
| Patient Selection | 1 | 2017 | 190 | 0.540 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 1900 | 0.530 |
Why?
|
| Adult | 15 | 2024 | 7598 | 0.530 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 140 | 0.530 |
Why?
|
| Middle Aged | 19 | 2024 | 7911 | 0.510 |
Why?
|
| Medicare | 1 | 2017 | 202 | 0.510 |
Why?
|
| Myocardial Infarction | 3 | 2023 | 238 | 0.500 |
Why?
|
| Exercise | 1 | 2020 | 489 | 0.500 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 255 | 0.450 |
Why?
|
| Electronic Health Records | 7 | 2020 | 681 | 0.430 |
Why?
|
| Sinusitis | 3 | 2017 | 14 | 0.420 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2024 | 119 | 0.400 |
Why?
|
| Pandemics | 3 | 2024 | 287 | 0.400 |
Why?
|
| California | 11 | 2024 | 2284 | 0.370 |
Why?
|
| Mass Screening | 4 | 2024 | 661 | 0.360 |
Why?
|
| Bariatric Surgery | 2 | 2023 | 128 | 0.360 |
Why?
|
| Risk Assessment | 5 | 2023 | 1097 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 205 | 0.320 |
Why?
|
| Guideline Adherence | 4 | 2017 | 155 | 0.300 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 1210 | 0.290 |
Why?
|
| Craniocerebral Trauma | 2 | 2017 | 10 | 0.290 |
Why?
|
| Troponin | 2 | 2023 | 9 | 0.270 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2016 | 23 | 0.270 |
Why?
|
| Breast Neoplasms | 3 | 2022 | 949 | 0.260 |
Why?
|
| Early Detection of Cancer | 4 | 2024 | 501 | 0.260 |
Why?
|
| Chest Pain | 2 | 2023 | 14 | 0.230 |
Why?
|
| Stroke | 2 | 2016 | 311 | 0.220 |
Why?
|
| Sampling Studies | 2 | 2020 | 51 | 0.210 |
Why?
|
| Aftercare | 1 | 2022 | 49 | 0.200 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 375 | 0.190 |
Why?
|
| Neoplasm Staging | 3 | 2017 | 325 | 0.190 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 318 | 0.190 |
Why?
|
| United States | 4 | 2017 | 3956 | 0.190 |
Why?
|
| Cohort Studies | 3 | 2023 | 2570 | 0.190 |
Why?
|
| Community Health Services | 1 | 2022 | 83 | 0.190 |
Why?
|
| Troponin I | 1 | 2021 | 8 | 0.190 |
Why?
|
| Critical Pathways | 1 | 2021 | 11 | 0.190 |
Why?
|
| Papillomavirus Vaccines | 1 | 2022 | 113 | 0.190 |
Why?
|
| Dementia | 1 | 2023 | 106 | 0.190 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 34 | 0.180 |
Why?
|
| Obesity, Morbid | 1 | 2022 | 120 | 0.180 |
Why?
|
| Patient Portals | 1 | 2021 | 24 | 0.180 |
Why?
|
| Telephone | 1 | 2021 | 161 | 0.180 |
Why?
|
| Heart Diseases | 1 | 2021 | 77 | 0.180 |
Why?
|
| Referral and Consultation | 1 | 2022 | 167 | 0.180 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 1309 | 0.170 |
Why?
|
| Exercise Test | 1 | 2020 | 44 | 0.170 |
Why?
|
| Hospitals, Community | 2 | 2017 | 23 | 0.170 |
Why?
|
| Hospice and Palliative Care Nursing | 1 | 2019 | 6 | 0.170 |
Why?
|
| House Calls | 1 | 2019 | 11 | 0.170 |
Why?
|
| Regression Analysis | 1 | 2020 | 297 | 0.170 |
Why?
|
| Home Care Services | 1 | 2019 | 22 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 250 | 0.160 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 187 | 0.160 |
Why?
|
| Algorithms | 1 | 2020 | 233 | 0.150 |
Why?
|
| Registries | 2 | 2017 | 471 | 0.150 |
Why?
|
| Education, Continuing | 1 | 2017 | 3 | 0.150 |
Why?
|
| Antimicrobial Stewardship | 1 | 2017 | 7 | 0.150 |
Why?
|
| Heart Failure | 1 | 2023 | 396 | 0.150 |
Why?
|
| Health Care Costs | 1 | 2019 | 228 | 0.140 |
Why?
|
| Income | 1 | 2017 | 90 | 0.140 |
Why?
|
| Delivery of Health Care | 2 | 2022 | 415 | 0.140 |
Why?
|
| Depression | 1 | 2022 | 502 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2017 | 215 | 0.140 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 211 | 0.130 |
Why?
|
| Odds Ratio | 4 | 2021 | 671 | 0.130 |
Why?
|
| Prospective Studies | 4 | 2023 | 1267 | 0.130 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 44 | 0.130 |
Why?
|
| Unnecessary Procedures | 1 | 2015 | 24 | 0.130 |
Why?
|
| Prognosis | 1 | 2017 | 606 | 0.130 |
Why?
|
| Comorbidity | 1 | 2017 | 594 | 0.130 |
Why?
|
| Critical Care | 1 | 2016 | 71 | 0.130 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 45 | 0.120 |
Why?
|
| Accelerometry | 1 | 2015 | 38 | 0.120 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 142 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 613 | 0.120 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2014 | 34 | 0.120 |
Why?
|
| Preventive Health Services | 1 | 2016 | 159 | 0.120 |
Why?
|
| Walking | 1 | 2015 | 85 | 0.120 |
Why?
|
| Maternal Exposure | 1 | 2014 | 60 | 0.120 |
Why?
|
| Air Pollutants | 1 | 2014 | 52 | 0.120 |
Why?
|
| Air Pollution | 1 | 2014 | 42 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2015 | 263 | 0.110 |
Why?
|
| Internet | 1 | 2016 | 231 | 0.110 |
Why?
|
| Ambulatory Care | 1 | 2015 | 244 | 0.110 |
Why?
|
| Health Maintenance Organizations | 1 | 2015 | 417 | 0.110 |
Why?
|
| Longitudinal Studies | 3 | 2023 | 710 | 0.110 |
Why?
|
| Chronic Disease | 1 | 2016 | 428 | 0.110 |
Why?
|
| Primary Health Care | 2 | 2017 | 766 | 0.110 |
Why?
|
| Logistic Models | 3 | 2020 | 926 | 0.090 |
Why?
|
| Weight Loss | 2 | 2023 | 303 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2014 | 958 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2024 | 382 | 0.080 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2017 | 53 | 0.070 |
Why?
|
| Canada | 2 | 2017 | 66 | 0.070 |
Why?
|
| Acute Disease | 2 | 2017 | 142 | 0.070 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 28 | 0.060 |
Why?
|
| Papanicolaou Test | 1 | 2024 | 37 | 0.060 |
Why?
|
| Vaginal Smears | 1 | 2024 | 48 | 0.060 |
Why?
|
| Papillomaviridae | 1 | 2024 | 52 | 0.060 |
Why?
|
| Perception | 1 | 2024 | 58 | 0.060 |
Why?
|
| Mammography | 2 | 2015 | 169 | 0.060 |
Why?
|
| Sleep | 1 | 2022 | 58 | 0.050 |
Why?
|
| Child | 2 | 2022 | 2474 | 0.050 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2022 | 57 | 0.050 |
Why?
|
| Social Class | 1 | 2022 | 120 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2022 | 32 | 0.050 |
Why?
|
| Angina, Unstable | 1 | 2021 | 7 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 322 | 0.050 |
Why?
|
| Coronary Angiography | 1 | 2021 | 21 | 0.050 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2021 | 22 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 2021 | 26 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 630 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2023 | 248 | 0.040 |
Why?
|
| Government Programs | 1 | 2020 | 11 | 0.040 |
Why?
|
| Health Priorities | 1 | 2020 | 26 | 0.040 |
Why?
|
| Research Personnel | 1 | 2020 | 27 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2022 | 211 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 60 | 0.040 |
Why?
|
| Occult Blood | 1 | 2021 | 153 | 0.040 |
Why?
|
| Oregon | 1 | 2019 | 171 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 304 | 0.040 |
Why?
|
| Natural Language Processing | 1 | 2020 | 57 | 0.040 |
Why?
|
| Infant | 1 | 2023 | 1171 | 0.040 |
Why?
|
| Biomarkers | 1 | 2020 | 301 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2022 | 1259 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 643 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2023 | 1409 | 0.040 |
Why?
|
| Washington | 1 | 2019 | 374 | 0.040 |
Why?
|
| Young Adult | 2 | 2015 | 2427 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 635 | 0.040 |
Why?
|
| Professional-Patient Relations | 1 | 2017 | 47 | 0.040 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2017 | 22 | 0.040 |
Why?
|
| Hospitalization | 1 | 2023 | 797 | 0.040 |
Why?
|
| Adolescent | 2 | 2015 | 3651 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2016 | 62 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 9 | 0.030 |
Why?
|
| Mid-Atlantic Region | 1 | 2015 | 9 | 0.030 |
Why?
|
| Northwestern United States | 1 | 2015 | 53 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 381 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 48 | 0.030 |
Why?
|
| Risk Factors | 1 | 2023 | 3325 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 39 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2016 | 106 | 0.030 |
Why?
|
| Vehicle Emissions | 1 | 2014 | 23 | 0.030 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2016 | 228 | 0.030 |
Why?
|
| Survivors | 1 | 2015 | 149 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 246 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 351 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2014 | 116 | 0.030 |
Why?
|
| Health Promotion | 1 | 2016 | 280 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 201 | 0.030 |
Why?
|
| Time Factors | 1 | 2015 | 1086 | 0.020 |
Why?
|
| Smoking | 1 | 2014 | 483 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 1494 | 0.020 |
Why?
|
Concepts
(181)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->